Effect of the Japanese herbal medicine, Boiogito, on the osteoarthritis of the knee with joint effusion.

Tokifumi Majima, Masahiro Inoue, Yasuhiko Kasahara, Tomohiro Onodera, Daisuke Takahashi, Akio Minami
{"title":"Effect of the Japanese herbal medicine, Boiogito, on the osteoarthritis of the knee with joint effusion.","authors":"Tokifumi Majima,&nbsp;Masahiro Inoue,&nbsp;Yasuhiko Kasahara,&nbsp;Tomohiro Onodera,&nbsp;Daisuke Takahashi,&nbsp;Akio Minami","doi":"10.1186/1758-2555-4-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Boiogito (Japanese herbal medicine, Tsumura Co. Tokyo, Japan) contains sinomenin which inhibits inflammatory reactions. Since sinomenine is a principle component of the Boiogito, there is a possibility of it being effective on osteoarthritis (OA) of the knee with joint effusion. However, there is no report concerning the effectiveness of Boiogito on knee OA. The objective of the present study is to investigate the therapeutic effect of Boiogito on OA of the knee associated with joint effusion in a comparative study among randomly assigned groups.</p><p><strong>Methods: </strong>Study was performed using 50 patients who were diagnosed with primary osteoarthritis of the knee with joint effusion. The patients were randomly assigned to two groups: one group (25 patients) using both loxoprofen (2-{4-[(2-oxocyclopentyl) methyl]} propanoic acid) and Boiogito and the other group (25 patients) using loxoprofen, and were evaluated during a 12 week observation period. The assessment parameters including knee scores in the Knee Society Rating System including Knee score and Functional scores, amount of joint effusion by joint puncture in clinically detected cases, the 36-items short form of the Medical Outcome Study Questionnaire (SF-36) as a measurement of health related quality of life were used.</p><p><strong>Results: </strong>The knee scores based on the Knee Society Rating System were improved in both groups. The staircase climbing up and down ability in the Knee society rating system functional score was significantly improved in the group using Boiogito and loxoprofen compared to the loxoprofen group. In the evaluation using SF-36, significant improvements were found in the scores in both groups in physical functioning after 12 weeks. The amount of joint fluid was significantly decreased at 4, 8 and 12 weeks compared to pre-administration baseline in the group using Boiogito and loxoprofen. A side effect of Boiogito, dry mouth, was found in one case. The symptom was mild and improved immediately after discontinuation of administration.</p><p><strong>Conclusion: </strong>The results indicated that Boiogito have a possibility for a treatment modality for joint effusion with osteoarthritis of the knee.</p>","PeriodicalId":88316,"journal":{"name":"Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT","volume":"4 ","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-2555-4-3","citationCount":"24","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1758-2555-4-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 24

Abstract

Background: Boiogito (Japanese herbal medicine, Tsumura Co. Tokyo, Japan) contains sinomenin which inhibits inflammatory reactions. Since sinomenine is a principle component of the Boiogito, there is a possibility of it being effective on osteoarthritis (OA) of the knee with joint effusion. However, there is no report concerning the effectiveness of Boiogito on knee OA. The objective of the present study is to investigate the therapeutic effect of Boiogito on OA of the knee associated with joint effusion in a comparative study among randomly assigned groups.

Methods: Study was performed using 50 patients who were diagnosed with primary osteoarthritis of the knee with joint effusion. The patients were randomly assigned to two groups: one group (25 patients) using both loxoprofen (2-{4-[(2-oxocyclopentyl) methyl]} propanoic acid) and Boiogito and the other group (25 patients) using loxoprofen, and were evaluated during a 12 week observation period. The assessment parameters including knee scores in the Knee Society Rating System including Knee score and Functional scores, amount of joint effusion by joint puncture in clinically detected cases, the 36-items short form of the Medical Outcome Study Questionnaire (SF-36) as a measurement of health related quality of life were used.

Results: The knee scores based on the Knee Society Rating System were improved in both groups. The staircase climbing up and down ability in the Knee society rating system functional score was significantly improved in the group using Boiogito and loxoprofen compared to the loxoprofen group. In the evaluation using SF-36, significant improvements were found in the scores in both groups in physical functioning after 12 weeks. The amount of joint fluid was significantly decreased at 4, 8 and 12 weeks compared to pre-administration baseline in the group using Boiogito and loxoprofen. A side effect of Boiogito, dry mouth, was found in one case. The symptom was mild and improved immediately after discontinuation of administration.

Conclusion: The results indicated that Boiogito have a possibility for a treatment modality for joint effusion with osteoarthritis of the knee.

Abstract Image

Abstract Image

Abstract Image

日本草药百良藤对膝关节积液性骨关节炎的疗效观察。
背景:Boiogito(日本草药,Tsumura Co. Tokyo, Japan)含有抑制炎症反应的青藤素。由于青藤碱是Boiogito的主要成分,因此有可能对膝关节积液性骨关节炎(OA)有效。然而,目前还没有关于Boiogito治疗膝关节OA疗效的报道。本研究的目的是在一项随机分组的比较研究中探讨Boiogito对膝关节积液相关的OA的治疗效果。方法:对50例诊断为原发性膝关节骨关节炎伴关节积液的患者进行研究。患者随机分为两组:一组(25例)同时使用loxoprofen(2-{4-[(2-氧环戊基)甲基]}propanoic acid)和Boiogito,另一组(25例)使用loxoprofen,在12周的观察期内进行评估。评估参数包括膝关节评分系统中的膝关节评分(包括膝关节评分和功能评分)、临床发现病例的关节穿刺关节积液量、36项简短的医疗结果研究问卷(SF-36)作为健康相关生活质量的衡量指标。结果:两组患者膝关节评分均有改善。与loxoprofen组相比,Boiogito组和loxoprofen组在膝关节社会评分系统功能评分中上下楼梯能力显著提高。在SF-36评估中,12周后两组的身体功能得分均有显著改善。与使用Boiogito和loxoprofen组的给药前基线相比,在第4、8和12周时关节液量显著减少。在一例病例中发现了Boiogito的副作用,口干。症状轻微,停药后立即好转。结论:Boiogito是治疗膝关节骨性关节炎关节积液的一种可行的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信